We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 58

India prohibits imports of cosmetics tested on animals
  • Shook Hardy & Bacon LLP
  • India
  • October 23 2014

Beginning November 13, 2014, India will no longer permit the "import of cosmetics tested on animals." The government reportedly took the action some


India’s Supreme Court orders checks on carbonated soft drinks
  • Shook Hardy & Bacon LLP
  • India
  • October 25 2013

India's India’s Supreme Court has reportedly accepted a government scientific panel’s finding that the chemical additives in soft drinks e.g


India to ban PET packaging for certain pharmaceuticals
  • Shook Hardy & Bacon LLP
  • India, USA
  • January 9 2014

Citing increasing concerns about potential adverse health effects, the Indian Health Ministry is reportedly considering prohibiting the use of


Indian Supreme Court rules Novartis cancer drug change not patentable
  • Shook Hardy & Bacon LLP
  • India
  • April 4 2013

The Supreme Court of India has rejected the patent application filed by Novartis AG for a beta crystalline form of its cancer drug Gleevec, also


House Subcommittee addresses policies blocking U.S. exports to India
  • Shook Hardy & Bacon LLP
  • India, USA
  • March 21 2013

The House Ways and Means Trade Subcommittee recently held a hearing on U.S.-India trade relations during which industry groups reportedly called on


UK and India to fund genomics and bioinformatics tech research
  • Shook Hardy & Bacon LLP
  • United Kingdom, India
  • April 4 2013

According to the U.K.'s Biotechnology and Biological Sciences Research Council (BBSRC), up to £10 million has been jointly pledged by the council and


Indian biotech association signs MOU with U.S.-based association
  • Shook Hardy & Bacon LLP
  • India, USA
  • October 18 2012

The Association of Biotechnology Led Enterprises (ABLE), representing biotechnology interests in India, has reportedly signed a memorandum of understanding (MOU) with the Washington Biotechnology and Biomedical Association (WBBA), Washington state’s life-sciences trade association


Indian drug industry disputes prohibition on brand names
  • Shook Hardy & Bacon LLP
  • India
  • November 1 2012

According to a news source, the Indian Drugs Manufacturing Association is gearing up to challenge action taken by the country’s drug controller to prevent the sale of medicines under brand names as part of an effort to accelerate sales of less-expensive generics


Scientists oppose SCI’s recommended moratorium on biotech crops
  • Shook Hardy & Bacon LLP
  • India
  • November 1 2012

After an expert committee appointed by the Supreme Court of India (SCI) recommended halting field trials of transgenic food crops for 10 years, biotechnologists, agricultural scientists and agribiotech-industry heads reportedly gathered in Bangalore to oppose the recommendations


India bans animal testing for cosmetics
  • Shook Hardy & Bacon LLP
  • India
  • July 12 2013

The Bureau of Indian Standards (BIS) has reportedly announced that it will implement a ban on animal testing for cosmetics, making it the first South